Literature DB >> 2207996

Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin.

N Ellerbroek1, F Holmes, E Singletary, H Evans, M Oswald, M McNeese.   

Abstract

The records of 42 patients who had axillary metastases compatible with a clinically occult breast primary were reviewed. Forty patients had mammography performed as part of their evaluations. Mastectomy yielded the primary tumor in one of 13 patients; biopsy yielded positive results in one of five. Among the 29 patients who did not undergo mastectomy, 16 received breast irradiation, and 13 were simply observed for signs of the primary tumor. For the patients who did not undergo mastectomy, the 5-year actuarial risk for appearance of a primary was 17% in the irradiated group versus 57% in the nonirradiated group (P = 0.06). Patterns of failure are correlated with stage and local and systemic therapy. The results affirm our belief that patients with axillary metastases histologically consistent with breast tumor should be treated identically to patients with similar nodal stages and proven breast primaries.

Entities:  

Mesh:

Year:  1990        PMID: 2207996     DOI: 10.1002/1097-0142(19901001)66:7<1461::aid-cncr2820660704>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

1.  Clinicopathological Characteristics of Non-palpable Breast Cancer Presenting as Axillary Mass.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

Review 2.  [Radiotherapeutic concepts in cancer of unknown primary site].

Authors:  D Krug; J Debus; F Sterzing
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

3.  Letter.

Authors:  G Cserni
Journal:  Pathol Oncol Res       Date:  1997-12       Impact factor: 3.201

4.  Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients.

Authors:  C Nanni; D Rubello; P Castellucci; M Farsad; R Franchi; S Toso; C Barile; L Rampin; O Nibale; S Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-02-22       Impact factor: 9.236

5.  Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.

Authors:  Hirofumi Asakura; Hitoshi Takashima; Masahiro Mitani; Reiji Haba; Reiko Seo; Koiku Yokoe; Yoshihiro Toyama; Motoomi Ohkawa
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

Review 6.  Unknown primary tumours.

Authors:  H F Hillen
Journal:  Postgrad Med J       Date:  2000-11       Impact factor: 2.401

7.  Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site.

Authors:  C S Karapetis; D Yip; K Virik; A Strickland; K Ryder; M Cowling; P G Harper
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

8.  Occult breast cancers manifesting as axillary lymph node metastasis in men: a two-case report.

Authors:  Sung Mo Hur; Dong Hui Cho; Se Kyung Lee; Min-Young Choi; Soo Youn Bae; Min Young Koo; Sangmin Kim; Seok-Jin Nam; Jeong Eon Lee; Jung-Hyun Yang
Journal:  J Breast Cancer       Date:  2012-09-28       Impact factor: 3.588

9.  Retrospective study of women presenting with axillary metastases from occult breast carcinoma.

Authors:  D Kay Blanchard; David R Farley
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

10.  Clinicopathologic characteristics of malignant non-hematopoietic tumors first presented as an axillary mass with emphasis on occult breast carcinoma.

Authors:  Thaer Khoury; Ana Lucia Ruano Mendez; Xuan Peng; Li Yan; Emilian Racila
Journal:  Int J Clin Oncol       Date:  2019-10-04       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.